Assertio Therapeutics (NASDAQ:ASRT) is a specialty pharmaceutical company focused on the development, sale, and marketing of branded prescription products designed to address unmet medical needs. Operating mainly in the United States, Assertio Therapeutics is dedicated to offering innovative solutions in neurology, orphan, and specialty medicines. The company's project portfolio includes a range of drugs aimed at providing effective treatments for conditions such as migraine, pain, and inflammation. Assertio Therapeutics is committed to improving patients' lives by delivering high-quality, innovative medicines that address complex health challenges. Through strategic alliances and groundbreaking research, the company aims to expand its product offerings and strengthen its position in the pharmaceutical industry.